Mangalore Institute Of Oncology Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 3.26 Cr
as on 17-11-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.48 Cr
as on 17-11-2024
- Satisfied Charges ₹ 14.79 Cr
as on 17-11-2024
- Revenue 28.13%
(FY 2023)
- Profit 72.15%
(FY 2023)
- Ebitda 41.47%
(FY 2023)
- Net Worth 17.34%
(FY 2023)
- Total Assets 22.58%
(FY 2023)
About Mangalore Institute Of Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.26 Cr.
The company currently has active open charges totaling ₹9.48 Cr. The company has closed loans amounting to ₹14.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mangalore Institute Of Oncology Private Limited India is Bailangadi Nayak as CFO. Ali Kumble, Kandel Akbar, Sanathakumar Hegde, and Six other members serve as directors at the Company.
- CIN/LLPIN
U85110KA2006PTC040626
- Company No.
040626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mangalore Institute Of Oncology?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bailangadi Nayak | CFO | 28-Jul-2023 | Current |
Board Members(9)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Krishna Prasad | Director | 28-Sep-2006 | Current |
Ali Kumble | Director | 28-Sep-2006 | Current |
Kandel Akbar | Director | 28-Sep-2006 | Current |
Sanathakumar Hegde | Director | 21-Jun-2010 | Current |
Suresh Rao | Director | 21-Jun-2010 | Current |
Dasapaiyya Rao | Additional Director | 12-Apr-2024 | Current |
Financial Performance of Mangalore Institute Of Oncology.
Mangalore Institute Of Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.13% increase. The company also saw a substantial improvement in profitability, with a 72.15% increase in profit. The company's net worth Soared by an impressive increase of 17.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mangalore Institute Of Oncology?
In 2023, Mangalore Institute Of Oncology had a promoter holding of 12.09% and a public holding of 87.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Indiana Hospital And Heart Institute LimitedActive 14 years 10 months
Ali Kumble and Yusuf Aramanayil are mutual person
- Indiana Hospital Private LimitedInactive For E-Filing 4 months 9 days
Ali Kumble and Yusuf Aramanayil are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 26 Dec 2023 | ₹8.51 Cr | Open |
Others Creation Date: 03 Jul 2023 | ₹9.78 M | Open |
Others Creation Date: 23 Mar 2018 | ₹2.53 M | Satisfied |
How Many Employees Work at Mangalore Institute Of Oncology?
Mangalore Institute Of Oncology has a workforce of 192 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mangalore Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangalore Institute Of Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.